Listening to Pink Floyd may do more than lift your mood—it could help doctors treat brain diseases such as Alzheimer's and Parkinson's, according to new research from the Israel Institute of Technology.
Scientists found that the band's 1979 hit 'Another Brick in the Wall' triggers measurable changes in the brain, making cells more active and responsive to future treatments. The study, published in the Journal of Controlled Release, involved playing different types of music to human volunteers and laboratory mice while monitoring their brains with MRI scanners.
Low-frequency sounds, like those in the iconic Pink Floyd song, caused brain cells to 'vibrate', activating specific regions and prompting the release of key proteins. This heightened activity could make it easier to deliver drugs across the blood-brain barrier, a protective membrane that blocks most medicines.
Lead researcher Professor Avi Schroeder said: 'Getting treatments into the brain has been one of the biggest challenges in neurology. When you go into a dance hall and hear the thump-thump-thump of the bass, it feels as though your body is vibrating. That is what is happening to the brain when Pink Floyd is played.'
The team found that exposure to low-frequency sound waves boosted the uptake of lipid nanoparticles—microscopic drug carriers—by up to ten times. This suggests sound could enhance the effectiveness of medicines targeting degenerative brain diseases. Professor Schroeder added: 'This low-frequency sound could be a valuable tool for enhancing drug delivery to specific brain areas, opening up new possibilities for precision medicine.'
The researchers said their findings point to music as a gentle, non-invasive way to help the brain respond better to treatment, proving that classic rock could have an even deeper impact than fans ever imagined.
